Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteries
Open Access
- 1 March 2004
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 57 (3) , 266-272
- https://doi.org/10.1136/jcp.2003.012419
Abstract
Background: Vascular endothelial growth factor (VEGF) mediates endothelial cell mitogenesis and enhances vascular permeability. The existence of single or multiple VEGF isoforms and receptors suggests that these proteins may have overlapping but distinct functions, which may be reflected in their cell expression and distribution. Methods: The localisation of VEGFs A–C and their receptors (VEGFRs 1–3, respectively) in 30 fresh human atherosclerotic arteries, 15 normal uterine arteries, and 15 saphenous veins using immunohistochemistry and western blotting. Results: Saphenous veins showed no staining for VEGF-B or VEGFR-2. Smooth muscle cells (SMCs) showed the strongest staining for VEGF-A, VEGF-B, VEGFR-1, and VEGFR-2 in all specimens. Conversely, VEGFR-3 and VEGF-C were predominately localised to the endothelial vasa vasorum in normal arteries, whereas medial SMCs showed the strongest staining in atherosclerotic arteries. Western blotting showed variations in VEGF protein localisation, with lower amounts of VEGF-B and VEGF-C in saphenous veins, compared with arterial tissue. Amounts of VEGF-C were lower than those of VEGF-A and VEGF-B in all specimens. Conclusion: This study provides direct evidence of the presence of VEGF proteins and receptors in human physiology and pathology, with variations in both the amounts of VEGF proteins expressed and their cellular distribution in normal arteries compared with atherosclerotic arteries. The presence of VEGFs A–C and their receptors in normal arterial tissue implies that VEGF functions may extend beyond endothelial cell proliferation. Reduced VEGFR-2 staining in atherosclerotic arteries may have implications for the atherosclerosis process and the development of vascular disease and its complications.Keywords
This publication has 28 references indexed in Scilit:
- Vascular Endothelial Growth Factor (VEGF) Expression in Human Coronary Atherosclerotic LesionsCirculation, 1998
- Mechanisms of angiogenesisNature, 1997
- Induction of VEGF and VEGF receptor gene expression by hypoxia: Divergent regulation in vivo and in vitroKidney International, 1997
- Functional Upregulation of the Vascular Endothelial Growth Factor Receptor KDR by HypoxiaCirculation, 1996
- Identification of Vascular Endothelial Growth Factor Determinants for Binding KDR and FLT-1 ReceptorsJournal of Biological Chemistry, 1996
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- Colocalisation of Vascular Endothelial Growth Factor and Its Flt-1 Receptor in Human PlacentaGrowth Factors, 1995
- Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.Circulation, 1994
- Hypothesis: Vasa Vasorum and Neovascularization of Human Coronary ArteriesNew England Journal of Medicine, 1984